Simvastatin treatment reduces the cholesterol content of membrane/lipid rafts, implicating the N -methyl-D-aspartate receptor in anxiety: a literature review. Braz. J. Pharm. Sci. [Internet]. 2017 Jan. 1 [cited 2024 May 4];53(1):e16102-. Available from: https://revistas.usp.br/bjps/article/view/131411